17th International Congress on Infectious Diseases
17thICID_FinalProg
17thICID_FinalProg
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<str<strong>on</strong>g>17th</str<strong>on</strong>g> INTERNATIONAL CONGRESS ON INFECTIOUS DISEASES<br />
Poster Presentati<strong>on</strong>s ~ Friday, March 4, 2016<br />
FRIDAY • March 4, 2016<br />
42.132 DC-SIGN and L-SIGN repeat-regi<strong>on</strong><br />
polymorphisms influence HIV-1 disease<br />
progressi<strong>on</strong> in slow and rapid progressors<br />
am<strong>on</strong>g perinatally-infected children in India<br />
N. Rajnala, B. P. Gopalan, R. D’Souza,<br />
A. Shet<br />
Bangalore (India)<br />
42.133 CD4 Levels >350 cell/µl at initiati<strong>on</strong> of<br />
opti<strong>on</strong> B+ Predict retenti<strong>on</strong> in care am<strong>on</strong>gst<br />
mothers in urban health facilities in Uganda<br />
D. Senjovu, P. Mugabe, U. Ssekabira<br />
Kampala (Uganda)<br />
42.134 An analysis of global HIV prevalence am<strong>on</strong>g<br />
refugees, asylum seekers, and migrants, using<br />
the US Bureau of the Census databank<br />
W. Shandera<br />
Houst<strong>on</strong>, TX (USA)<br />
42.135 Mitoch<strong>on</strong>drial dysfuncti<strong>on</strong> am<strong>on</strong>g HIV-1<br />
infected patients of South India and<br />
evaluati<strong>on</strong> of mitoch<strong>on</strong>drial DNA as a<br />
biomarker of mitoch<strong>on</strong>drial toxicity<br />
D. Subashini 1 , T. R. Dinesha 1 , S. Gomathi 1 ,<br />
J. Boobalan 1 , C. Swathirajan 1 , L. Samuel 1 ,<br />
S. Po<strong>on</strong>gulali 1 , D. Chitra 1 , R. Srirama 2 ,<br />
S. Mothi 2 , S. S. Solom<strong>on</strong> 1 , S. Solom<strong>on</strong> 1 ,<br />
S. Saravanan 1 , P. Balakrishnan 1<br />
1<br />
Chennai (India), 2 Mysore (India)<br />
42.136 Pre-exposure Prophylaxis (PrEP): Attitudes,<br />
preferences and risk compensati<strong>on</strong> behavior<br />
am<strong>on</strong>g men who have sex with other men<br />
(MSM) in India<br />
C. K. Uthappa 1 , S. Pal 2 , R. Panth 2 , R. Allam 1 ,<br />
V. Yeldandi 3<br />
1<br />
Hyderabad (India), 2 New Delhi (India),<br />
3<br />
Chicago, IL (USA)<br />
42.137 Health related quality of life of HIV/AIDS<br />
patients <strong>on</strong> highly active antiretroviral<br />
therapy in Ahmadu Bello University Teaching<br />
Hospital<br />
S. S. Yahaya 1 , A. A. Olorukooba 2 , R. Yusuf 2 ,<br />
H. Abdulrahman 2 , L. Amadu 2<br />
1<br />
Katsina (Nigeria), 2 Zaria (Nigeria)<br />
42.138 Current problems in serologically based<br />
diagnostic algorithm of HIV 1/2: The<br />
re-evaluati<strong>on</strong> of immunodot blot assays<br />
in HIV 1/2 verificati<strong>on</strong> in Turkey<br />
P. Yuksel, R. Caliskan, M. Kuskucu, S. Islak<br />
Mutcali, E. Kosan, H. Kırkoyun Uysal,<br />
Z. Habip, A. Abdelkerem, B. Mete,<br />
S. Saribas, E. B<strong>on</strong>abi, I. Birinci,<br />
O. Dinc, K. Midilli, B. Kocazeybek<br />
Istanbul (Turkey)<br />
Infecti<strong>on</strong> C<strong>on</strong>trol<br />
42.139 Uptake of intermittent preventive therapy<br />
am<strong>on</strong>g pregnant women attending antenatal<br />
clinics in public and registered private health<br />
facilities in Oyo State, Nigeria<br />
A. O. Akpasa 1 , A. Adebayo 1 , J. Onyilo 1 ,<br />
B. Ahmed 1 , T. O. Ladipo 1 , Y. Oke 2 ,<br />
A. Karim-Mohammed 1 , O. Adeusi 2 ,<br />
B. Aiyenigba 2<br />
1<br />
Ibadan (Nigeria), 2 Abuja (Nigeria)<br />
42.140 Prospective cohort study <strong>on</strong> rectal<br />
col<strong>on</strong>izati<strong>on</strong> with Carbapenem Resistant<br />
Enterobactericeae in patients admitted in<br />
a tertiary care hospital<br />
R. Arjun, P. Patil, P. Gupta, P. Wagle<br />
Trivandrum (India)<br />
42.141 Evaluati<strong>on</strong> of antimicrobial and disinfectant<br />
resistant bacteria isolated from the<br />
envir<strong>on</strong>ment of a University Health Centre<br />
O. O. Ayepola, L. O. Egwari,<br />
G. I. Olasehinde<br />
Ota (Nigeria)<br />
42.142 Tetanus and use of magnesium in resource<br />
limited country<br />
A. Basher<br />
Mymensingh (Bangladesh)<br />
42.143 The role of toxin-antitoxin systems in the<br />
survival of multidrug tolerant pathogens and<br />
designing of new approaches to treat them<br />
R. K. Chaudhary 1 , R. Narain 2 , G. Singh 3 ,<br />
A. Kumar 1 , S. Ram 1<br />
1<br />
Greater Noida (India), 2 Jaunpur (India),<br />
3<br />
New Delhi (India),<br />
42.144 Impact of antimicrobial stewardship in<br />
collaborati<strong>on</strong> with infecti<strong>on</strong> c<strong>on</strong>trol <strong>on</strong><br />
hospital-acquired infecti<strong>on</strong> rates in a<br />
subspecialty cancer treatment facility<br />
M. Chowdhury, D. Miller, M. Lewis,<br />
M. Niesley, T. Patel<br />
Philadelphia, PA (USA)<br />
42.145 Inhibiti<strong>on</strong> of Japanese encephalitis virus<br />
infecti<strong>on</strong> by biogenic catechin silver<br />
nanoparticles: An in-vitro study<br />
P. Chowdhury 1 , T. Bora 2 , S. A. Khan 2 ,<br />
B. Chakraborty 3 , K. Senapati 4 , M. Sengupta 3 ,<br />
S. Borchetia 1 , T. Bandyopadhyay 1<br />
1<br />
Jorhat (India), 2 Dibrugarh (India),<br />
3<br />
Silchar (India), 4 Guwahati (India)<br />
68 ~ FINAL PROGRAM #<str<strong>on</strong>g>17th</str<strong>on</strong>g>ICID